Gene manipulated peritoneal cell patch repairs infarcted myocardium.

Area of Science:

• Regenerative Medicine
• Cardiovascular Biology
• Biomaterials Science

Background:

• Myocardial infarction (MI) leads to significant cardiac scarring and dysfunction.
• Current treatments for MI have limitations in repairing scarred myocardium.
• Gene-modified cell therapies offer potential for cardiac repair.

Purpose of the Study:

• To develop and evaluate a gene-engineered mesenchymal stem cell (MSC)-seeded peritoneum patch for myocardial repair post-MI.
• To investigate the role of CXCR4 overexpression in MSCs for cardiac regeneration.
• To assess the therapeutic efficacy of the cell patch in a rat model of MI.

Main Methods:

• Mesenchymal stem cells (MSCs) were genetically engineered to overexpress CXCR4 and green fluorescent protein (GFP).
• Cells were cultured on a peritoneum substrate to create a cell patch.
• The cell patch was implanted onto the scarred myocardium in a rat model of myocardial infarction.
• Cardiac function, fibrosis, and vascularization were assessed one month post-implantation.

Main Results:

• MSC patches overexpressing CXCR4 (MSC(CXCR4)) showed enhanced chemokine expression.
• Significant engraftment of GFP-positive cells was observed in the infarcted myocardium with MSC(CXCR4) patches.
• MSC(CXCR4) patches significantly improved left ventricular anterior wall thickness, reduced fibrosis, and enhanced cardiac function compared to controls.
• These benefits were not observed with MSCs lacking CXCR4 (MSC(siRNA)).

Conclusions:

• Gene-engineered MSC-seeded peritoneum patches can effectively promote cardiac repair after myocardial infarction.
• Overexpression of CXCR4 in MSCs enhances their therapeutic potential for cardiac regeneration.
• This approach demonstrates potential for improving tissue nutrition, reducing adverse remodeling, and enhancing heart function post-MI.